Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment

Hyeon Sook Suh, Benjamin Gelman, Sunhee C. Lee

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Progranulin (PGRN) is a highly unusual molecule with both neuronal and microglial expression with two seemingly unrelated functions, i.e., as a neuronal growth factor and a modulator of neuroinflammation. Haploinsufficiency due to loss of function mutations lead to a fatal presenile dementing illness (frontotemporal lobar degeneration), indicating that adequate expression of PGRN is essential for successful aging. PGRN might be a particularly relevant factor in the pathogenesis of HIV encephalitis (HIVE) and HIV-associated neurocognitive disorders (HAND). We present emerging data and a review of the literature which show that cells of myeloid lineage such as macrophages and microglia are the primary sources of PGRN and that PGRN expression contributes to pathogenesis of CNS diseases. We also present evidence that PGRN is a macrophage antiviral cytokine. For example, PGRN mRNA and protein expression are significantly upregulated in brain specimens with HIVE, and in HIV-infected microglia in vitro. Paradoxically, our preliminary CHARTER data analyses indicate that lower PGRN levels in CSF trended towards an association with HAND, particularly in those without detectable virus. Based upon these findings, we introduce the hypothesis that PGRN plays dual roles in modulating antiviral immunity and neuronal dysfunction in the context of HIV infection. In the presence of active viral replication, PGRN expression is increased functioning as an anti-viral factor as well as a neuroprotectant. In the absence of active HIV replication, ongoing inflammation or other stressors suppress PGRN production from macrophages/microglia contributing to neurocognitive dysfunction. We propose CSF PGRN as a candidate surrogate marker for HAND.

Original languageEnglish (US)
Pages (from-to)117-132
Number of pages16
JournalJournal of NeuroImmune Pharmacology
Volume9
Issue number2
DOIs
StatePublished - 2014

Fingerprint

HIV
Pathology
Microglia
Macrophages
Encephalitis
Antiviral Agents
Frontotemporal Lobar Degeneration
Haploinsufficiency
Central Nervous System Diseases
Neuroprotective Agents
Cell Lineage
HIV Infections
Immunity
Intercellular Signaling Peptides and Proteins
Biomarkers
Cytokines
Viruses
Inflammation
Messenger RNA
Mutation

Keywords

  • Cytokines
  • Growth factor
  • HIV encephalitis (HIVE)
  • HIV-associated neurocognitive disorder (HAND)
  • Human
  • Innate immunity
  • Microglia

ASJC Scopus subject areas

  • Pharmacology
  • Immunology and Allergy
  • Immunology
  • Neuroscience (miscellaneous)

Cite this

Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment. / Suh, Hyeon Sook; Gelman, Benjamin; Lee, Sunhee C.

In: Journal of NeuroImmune Pharmacology, Vol. 9, No. 2, 2014, p. 117-132.

Research output: Contribution to journalArticle

@article{324aae94e5064523b06d6f236ee89582,
title = "Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment",
abstract = "Progranulin (PGRN) is a highly unusual molecule with both neuronal and microglial expression with two seemingly unrelated functions, i.e., as a neuronal growth factor and a modulator of neuroinflammation. Haploinsufficiency due to loss of function mutations lead to a fatal presenile dementing illness (frontotemporal lobar degeneration), indicating that adequate expression of PGRN is essential for successful aging. PGRN might be a particularly relevant factor in the pathogenesis of HIV encephalitis (HIVE) and HIV-associated neurocognitive disorders (HAND). We present emerging data and a review of the literature which show that cells of myeloid lineage such as macrophages and microglia are the primary sources of PGRN and that PGRN expression contributes to pathogenesis of CNS diseases. We also present evidence that PGRN is a macrophage antiviral cytokine. For example, PGRN mRNA and protein expression are significantly upregulated in brain specimens with HIVE, and in HIV-infected microglia in vitro. Paradoxically, our preliminary CHARTER data analyses indicate that lower PGRN levels in CSF trended towards an association with HAND, particularly in those without detectable virus. Based upon these findings, we introduce the hypothesis that PGRN plays dual roles in modulating antiviral immunity and neuronal dysfunction in the context of HIV infection. In the presence of active viral replication, PGRN expression is increased functioning as an anti-viral factor as well as a neuroprotectant. In the absence of active HIV replication, ongoing inflammation or other stressors suppress PGRN production from macrophages/microglia contributing to neurocognitive dysfunction. We propose CSF PGRN as a candidate surrogate marker for HAND.",
keywords = "Cytokines, Growth factor, HIV encephalitis (HIVE), HIV-associated neurocognitive disorder (HAND), Human, Innate immunity, Microglia",
author = "Suh, {Hyeon Sook} and Benjamin Gelman and Lee, {Sunhee C.}",
year = "2014",
doi = "10.1007/s11481-013-9495-z",
language = "English (US)",
volume = "9",
pages = "117--132",
journal = "Journal of NeuroImmune Pharmacology",
issn = "1557-1890",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment

AU - Suh, Hyeon Sook

AU - Gelman, Benjamin

AU - Lee, Sunhee C.

PY - 2014

Y1 - 2014

N2 - Progranulin (PGRN) is a highly unusual molecule with both neuronal and microglial expression with two seemingly unrelated functions, i.e., as a neuronal growth factor and a modulator of neuroinflammation. Haploinsufficiency due to loss of function mutations lead to a fatal presenile dementing illness (frontotemporal lobar degeneration), indicating that adequate expression of PGRN is essential for successful aging. PGRN might be a particularly relevant factor in the pathogenesis of HIV encephalitis (HIVE) and HIV-associated neurocognitive disorders (HAND). We present emerging data and a review of the literature which show that cells of myeloid lineage such as macrophages and microglia are the primary sources of PGRN and that PGRN expression contributes to pathogenesis of CNS diseases. We also present evidence that PGRN is a macrophage antiviral cytokine. For example, PGRN mRNA and protein expression are significantly upregulated in brain specimens with HIVE, and in HIV-infected microglia in vitro. Paradoxically, our preliminary CHARTER data analyses indicate that lower PGRN levels in CSF trended towards an association with HAND, particularly in those without detectable virus. Based upon these findings, we introduce the hypothesis that PGRN plays dual roles in modulating antiviral immunity and neuronal dysfunction in the context of HIV infection. In the presence of active viral replication, PGRN expression is increased functioning as an anti-viral factor as well as a neuroprotectant. In the absence of active HIV replication, ongoing inflammation or other stressors suppress PGRN production from macrophages/microglia contributing to neurocognitive dysfunction. We propose CSF PGRN as a candidate surrogate marker for HAND.

AB - Progranulin (PGRN) is a highly unusual molecule with both neuronal and microglial expression with two seemingly unrelated functions, i.e., as a neuronal growth factor and a modulator of neuroinflammation. Haploinsufficiency due to loss of function mutations lead to a fatal presenile dementing illness (frontotemporal lobar degeneration), indicating that adequate expression of PGRN is essential for successful aging. PGRN might be a particularly relevant factor in the pathogenesis of HIV encephalitis (HIVE) and HIV-associated neurocognitive disorders (HAND). We present emerging data and a review of the literature which show that cells of myeloid lineage such as macrophages and microglia are the primary sources of PGRN and that PGRN expression contributes to pathogenesis of CNS diseases. We also present evidence that PGRN is a macrophage antiviral cytokine. For example, PGRN mRNA and protein expression are significantly upregulated in brain specimens with HIVE, and in HIV-infected microglia in vitro. Paradoxically, our preliminary CHARTER data analyses indicate that lower PGRN levels in CSF trended towards an association with HAND, particularly in those without detectable virus. Based upon these findings, we introduce the hypothesis that PGRN plays dual roles in modulating antiviral immunity and neuronal dysfunction in the context of HIV infection. In the presence of active viral replication, PGRN expression is increased functioning as an anti-viral factor as well as a neuroprotectant. In the absence of active HIV replication, ongoing inflammation or other stressors suppress PGRN production from macrophages/microglia contributing to neurocognitive dysfunction. We propose CSF PGRN as a candidate surrogate marker for HAND.

KW - Cytokines

KW - Growth factor

KW - HIV encephalitis (HIVE)

KW - HIV-associated neurocognitive disorder (HAND)

KW - Human

KW - Innate immunity

KW - Microglia

UR - http://www.scopus.com/inward/record.url?scp=84896548321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896548321&partnerID=8YFLogxK

U2 - 10.1007/s11481-013-9495-z

DO - 10.1007/s11481-013-9495-z

M3 - Article

VL - 9

SP - 117

EP - 132

JO - Journal of NeuroImmune Pharmacology

JF - Journal of NeuroImmune Pharmacology

SN - 1557-1890

IS - 2

ER -